Shaji Kumar, MD¹, Suzanne Hayman^1*, Francis Buadi^1*, Martha Lacy^1*, Keith Stewart^2*, Jacob Allred^1*, Kristina Lauman^1*, Tammy McCarty^1*, Leif Bergsagel^2*, David Dingli^1*, Rafael Fonseca, MD², Morie Gertz^1*, Philip Greipp^1*, John Lust^1*, Stephen Russell^1*, Craig Reeder^2*, Thomas Witzig^1*, Steven Zeldenrust^1*, Robert Kyle^1*, S. Vincent Rajkumar^1* and Angela Dispenzieri^1*

¹Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic Scottsdale, Scottsdale, AZ

Paul Richardson, MD¹, Sagar Lonial, MD², Andrzej Jakubowiak, MD, PhD³, Sundar Jagannath, MD⁴, Noopur S Raje, MD^5*, David Avigan, MD^6*, Irene M Ghobrial, MD^1*, Robert L Schlossman, MD¹, Amitabha Mazumder, MD⁴, Nikhil C Munshi, MD¹, David H Vesole, MD, PhD⁴, Robin Joyce, MD^6*, Deborah Doss, RN, OCN^1*, Diane L Warren, BS^1*, Stephen W Hayes^1*, Sarah Kaster, BS^5*, Carol Delaney, BSN^6*, Marisa Lauria, BA^6*, Constantine Mitsiades, MD, PhD¹, Teru Hideshima, MD, PhD¹, Robert D. Knight, MD⁷, Dixie-Lee Esseltine, MD⁸ and Kenneth C Anderson, MD¹

¹Dana-Farber Cancer Institute, Boston, MA
²Hematology and Medical Oncology, Emory Univesity, Atlanta, GA
³Univ. of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁴St. Vincent's Comprehensive Cancer Center, New York, NY
⁵Massachusetts General Hospital, Boston, MA
⁶Beth Israel Deaconess Medical Center, Boston, MA
⁷Celgene Corporation, Summit, NJ
⁸Millennium Pharmaceuticals: The Takeda Oncology Company, Cambridge, MA

Shaji Kumar, MD¹, Ian W Flinn, MD, PhD², Stephen J. Noga, MD, PhD³, Parameswaran Hari, MD, MS⁴, Robert M. Rifkin, MD⁵, Natalie Scott Callander, MD⁶, Manish Bhandari, MD^7*, Jeffrey Lee Wolf, MD^8*, Cristina Gasparetto, MD⁹, Amrita Krishnan, MD, FACP¹⁰, Daren D Grosman, MD, PhD^11*, Jonathan Glass, MD^12*, Entezam Asim Sahovic, MD^13*, Hongliang Shi, MS^14*, Iain J. Webb, MD¹⁵, Paul Richardson, MD¹⁶ and S. Vincent Rajkumar, MD¹⁷

¹Hematology, Mayo Clinic, Rochester, MN
²Sarah Cannon Research Institute, TN
³Medical Oncology/Hematology, Alvin & Lois Lapidus Cancer Institute, Baltimore, MD
⁴Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research, Milwaukee, WI
⁵Rocky Mountain Cancer Center, Denver, CO
⁶University of Wisconsin, Madison, WI
⁷Research, The Christ Hospital, Cincinnati, OH
⁸University of California, SF, San Francisco, CA
⁹Cellular Therapy, Duke Univ. Medical Center, Durham, NC
¹⁰City of Hope National Medical Center, Duarte, CA
¹¹Memorial Healthcare Cancer Center, Hollywood, FL
¹²Feist-Weiller Cancer Center/Department of Medicine, LSUHSC- Shreveport, Shreveport, LA
¹³Western Pennsylvania Hospital, Pittsburgh, PA
¹⁴Clinical Biostatistics, Millennium Pharmaceuticals: The Takeda Oncology Company, Cambridge, MA
¹⁵Millennium Pharmaceuticals: The Takeda Oncology Company, Cambridge, MA
¹⁶Dana-Farber Cancer Institute, Boston, MA
¹⁷Mayo Clinic College of Medicine, Rochester, MN

William Bensinger^1*, Sundar Jagannath, MD², Robert Vescio, MD³, Elber S. Camacho, MD⁴, Jeffrey Lee Wolf^5*, David H Irwin, MD^6*, Gerardo Capo III, MD^7*, Marti McKinley^8*, Phyllis Potts^8*, David H. Vesole, MD, PhD², Amitabha Mazumder, MD², Dixie-Lee Esseltine, MD⁹, Pamela Becker^1*, John Crowley, PhD¹⁰ and Brian GM Durie, MD³

¹Research Center, Fred Hutchinson Cancer, Seattle, WA
²St. Vincent's Comprehensive Cancer Center, New York, NY
³Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA
⁴Comprehensive Cancer Center of the Desert, Palm Springs, CA
⁵University of California San Francisco, San Francisco, CA
⁶Alta Bates Summit Comprehensive Cancer Center, Berkeley, CA
⁷Trinitas Comprehensive Cancer Center, Elizabeth, NJ
⁸Research Network, Aptium Oncology, Inc., Los Angeles, CA
⁹Millennium Pharmaceuticals: The Takeda Oncology Company, Cambridge, MA
¹⁰Cancer Research & Biostatistics, Seattle, WA

Prashant Kapoor, MD^1*, Shaji Kumar, MD¹, Rafael Fonseca, MD², Martha Q. Lacy, MD³, Thomas E Witzig, MD^1*, Suzanne R. Hayman, MD¹, Angela Dispenzieri, MD⁴, Francis Buadi, MBChB^5*, P. Leif Bergsagel, MD⁶, Morie Gertz, MD^1*, Robert Dalton, MD⁷, Joseph Mikhael, MD⁸, David Dingli, MD, PhD⁴, Craig B. Reeder, MD⁹, John A. Lust, MD, PhD¹, Stephen Russell, MD, PhD^1*, Vivek Roy, MD, FACP¹⁰, Steven R. Zeldenrust, M.D., Ph.D.¹, Keith Stewart, MBChB, MBA⁶, Robert A Kyle, MD¹¹, Philip R. Greipp, MD^1* and S. Vincent Rajkumar, MD^11*

¹Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic Scottsdale, Scottsdale, AZ
³Internal Medicine/Hematology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN
⁵Mayo clinic college of medicine, Rochester, MN
⁶Mayo Clinic, Scottsdale, AZ
⁷ISJ-Mayo Health System, Mankato, MN
⁸Division of Hematology, Mayo Clinic, Scottsdale Campus, Scottsdale, AZ
⁹Hematology, Mayo Clinic Arizona, Scottsdale, AZ
¹⁰Mayo Clinic, Jacksonville, FL
¹¹Hematology, College of Medicine, Mayo Clinic, Rochester, MN

Sophia Adamia, Ph.D^1*, Herve AvetLoiseau, MD^2*, Samirkumar B Amin, MBBS^3*, Yu-Tzu Tai, PhD⁴, Steven P. Treon, MD, PhD^5*, Philippe Moreau, MD^6*, Stephane Minvielle, Ph.D^2*, Cheng Li, Ph.D^7*, Kenneth C Anderson, MD³ and Nikhil C. Munshi, MD⁸

¹Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Hematology Department, Hopital de Nantes, Nantes, France
³Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Medical Oncology, Dana-Farber Cancer Inst., Boston, MA
⁵Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Hematology Department, Hopital de Nantes, Nantes, 44093, France, France
⁷Biostatistics & Computational Biology, Dana-Farber Cancer Istitute & HArvard Medical School, Boston, MA
⁸Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston VA Cancer Healthcare System, Boston, MA